Search Results

Read the latest news from Seqirus, a world leader in developing and producing influenza vaccines.

https://www.cslseqirus.us/news

CSL Seqirus is the only manufacturer to offer a differentiated influenza vaccine portfolio for all eligible age groups in the U.S.

https://www.cslseqirus.us/news/csl-seqirus-commences-shipping-its-portfolio-of-influenza-vaccines

Influenza is a common, highly contagious infection that can lead to life-threatening complications. Learn more about influenza and our cutting-edge vaccines.

https://www.cslseqirus.us/expertise/influenza

CSL Seqirus is a world leader in developing and producing influenza vaccines. Learn more about how we work with our partners to protect the global community.

https://www.cslseqirus.us/products

CSL Seqirus brings multifaceted expertise to influenza prevention, employing both egg and cell-based technologies to meet the global community's needs.

https://www.cslseqirus.us/expertise

Learn more about how we're leveraging cutting-edge technology and proven expertise to develop influenza vaccines and respond to pandemic threats.

https://www.cslseqirus.us/

CSL Seqirus has been on the front line of pandemic preparedness for more than a century. Learn more about our rapid vaccine production capabilities.

https://www.cslseqirus.us/expertise/influenza/pandemic-response-solutions

CSL Seqirus stands with our partners on the front line of public health. We are the largest fully integrated commercialisation partner in Australia and New Zealand. Learn more.

https://www.cslseqirus.us/partnering

CSL Seqirus is a global influenza vaccine company developing innovative solutions to ensure epidemic and pandemic preparedness throughout the world.

https://www.cslseqirus.us/our-company

CSL Seqirus is the only manufacturer to offer a differentiated influenza vaccine for all eligible people aged six months and older in the United States.

https://www.cslseqirus.us/news/csl-seqirus-begins-shipping-its-portfolio-of-influenza-vaccines-for-the-2024-25-flu-season